Transformation of SOX9+ cells by Pten deletion synergizes with steatotic liver injury to drive development of hepatocellular and cholangiocarcinoma

Abstract SOX9 (Sex-determining region Y Box 9) is a well-characterized transcription factor that is a marker for progenitor cells in various tissues. In the liver, cells delineated by SOX9 are responsible for regenerating liver parenchyma when cell proliferation is impaired following chronic injury....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jingyu Chen, Anketse Debebe, Ni Zeng, Janel Kopp, Lina He, Maike Sander, Bangyan L. Stiles
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/1db28909f5914c96b75d5b4abc666999
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1db28909f5914c96b75d5b4abc666999
record_format dspace
spelling oai:doaj.org-article:1db28909f5914c96b75d5b4abc6669992021-12-02T15:57:20ZTransformation of SOX9+ cells by Pten deletion synergizes with steatotic liver injury to drive development of hepatocellular and cholangiocarcinoma10.1038/s41598-021-90958-12045-2322https://doaj.org/article/1db28909f5914c96b75d5b4abc6669992021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-90958-1https://doaj.org/toc/2045-2322Abstract SOX9 (Sex-determining region Y Box 9) is a well-characterized transcription factor that is a marker for progenitor cells in various tissues. In the liver, cells delineated by SOX9 are responsible for regenerating liver parenchyma when cell proliferation is impaired following chronic injury. However, whether these SOX9+ cells play a role in liver carcinogenesis has not been fully understood, although high SOX9 expression has been linked to poor survival outcome in liver cancer patients. To address this question, we developed a liver cancer mouse model (Pten loxP/loxP ; Sox9-Cre ERT+ ; R26R YFP ) where tumor suppressor Pten (phosphatase and tensin homolog deleted on chromosome ten) is deleted in SOX9+ cells following tamoxifen injection. In this paper, we employ lineage-tracing to demonstrate the tumorigenicity potential of the Pten -, SOX9+ cells. We show that these cells are capable of giving rise to mixed-lineage tumors that manifest features of both hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (CCA). Our results suggest that PTEN loss induces the transformation of SOX9+ cells. We further show that to activate these transformed SOX9+ cells, the presence of liver injury is crucial. Liver injury, induced by hepatotoxin 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) or high-fat diet (HFD), substantially increases tumor incidence and accelerates liver carcinogenesis from SOX9+ cells in Pten null mice but not in control mice. We further examine the mechanisms underlying tumor formation in this model to show that concurrent with the induction of niche signal (i.e., Wnt signaling), liver injury significantly stimulates the expansion of tumor-initiating cells (TICs). Together, these data show that (1) SOX9+ cells have the potential to become TICs following the primary transformation (i.e. Pten deletion) and that (2) liver injury is necessary for promoting the activation and proliferation of transformed SOX9+ cells, resulting in the genesis of mixed-lineage liver tumors.Jingyu ChenAnketse DebebeNi ZengJanel KoppLina HeMaike SanderBangyan L. StilesNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-17 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jingyu Chen
Anketse Debebe
Ni Zeng
Janel Kopp
Lina He
Maike Sander
Bangyan L. Stiles
Transformation of SOX9+ cells by Pten deletion synergizes with steatotic liver injury to drive development of hepatocellular and cholangiocarcinoma
description Abstract SOX9 (Sex-determining region Y Box 9) is a well-characterized transcription factor that is a marker for progenitor cells in various tissues. In the liver, cells delineated by SOX9 are responsible for regenerating liver parenchyma when cell proliferation is impaired following chronic injury. However, whether these SOX9+ cells play a role in liver carcinogenesis has not been fully understood, although high SOX9 expression has been linked to poor survival outcome in liver cancer patients. To address this question, we developed a liver cancer mouse model (Pten loxP/loxP ; Sox9-Cre ERT+ ; R26R YFP ) where tumor suppressor Pten (phosphatase and tensin homolog deleted on chromosome ten) is deleted in SOX9+ cells following tamoxifen injection. In this paper, we employ lineage-tracing to demonstrate the tumorigenicity potential of the Pten -, SOX9+ cells. We show that these cells are capable of giving rise to mixed-lineage tumors that manifest features of both hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (CCA). Our results suggest that PTEN loss induces the transformation of SOX9+ cells. We further show that to activate these transformed SOX9+ cells, the presence of liver injury is crucial. Liver injury, induced by hepatotoxin 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) or high-fat diet (HFD), substantially increases tumor incidence and accelerates liver carcinogenesis from SOX9+ cells in Pten null mice but not in control mice. We further examine the mechanisms underlying tumor formation in this model to show that concurrent with the induction of niche signal (i.e., Wnt signaling), liver injury significantly stimulates the expansion of tumor-initiating cells (TICs). Together, these data show that (1) SOX9+ cells have the potential to become TICs following the primary transformation (i.e. Pten deletion) and that (2) liver injury is necessary for promoting the activation and proliferation of transformed SOX9+ cells, resulting in the genesis of mixed-lineage liver tumors.
format article
author Jingyu Chen
Anketse Debebe
Ni Zeng
Janel Kopp
Lina He
Maike Sander
Bangyan L. Stiles
author_facet Jingyu Chen
Anketse Debebe
Ni Zeng
Janel Kopp
Lina He
Maike Sander
Bangyan L. Stiles
author_sort Jingyu Chen
title Transformation of SOX9+ cells by Pten deletion synergizes with steatotic liver injury to drive development of hepatocellular and cholangiocarcinoma
title_short Transformation of SOX9+ cells by Pten deletion synergizes with steatotic liver injury to drive development of hepatocellular and cholangiocarcinoma
title_full Transformation of SOX9+ cells by Pten deletion synergizes with steatotic liver injury to drive development of hepatocellular and cholangiocarcinoma
title_fullStr Transformation of SOX9+ cells by Pten deletion synergizes with steatotic liver injury to drive development of hepatocellular and cholangiocarcinoma
title_full_unstemmed Transformation of SOX9+ cells by Pten deletion synergizes with steatotic liver injury to drive development of hepatocellular and cholangiocarcinoma
title_sort transformation of sox9+ cells by pten deletion synergizes with steatotic liver injury to drive development of hepatocellular and cholangiocarcinoma
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/1db28909f5914c96b75d5b4abc666999
work_keys_str_mv AT jingyuchen transformationofsox9cellsbyptendeletionsynergizeswithsteatoticliverinjurytodrivedevelopmentofhepatocellularandcholangiocarcinoma
AT anketsedebebe transformationofsox9cellsbyptendeletionsynergizeswithsteatoticliverinjurytodrivedevelopmentofhepatocellularandcholangiocarcinoma
AT nizeng transformationofsox9cellsbyptendeletionsynergizeswithsteatoticliverinjurytodrivedevelopmentofhepatocellularandcholangiocarcinoma
AT janelkopp transformationofsox9cellsbyptendeletionsynergizeswithsteatoticliverinjurytodrivedevelopmentofhepatocellularandcholangiocarcinoma
AT linahe transformationofsox9cellsbyptendeletionsynergizeswithsteatoticliverinjurytodrivedevelopmentofhepatocellularandcholangiocarcinoma
AT maikesander transformationofsox9cellsbyptendeletionsynergizeswithsteatoticliverinjurytodrivedevelopmentofhepatocellularandcholangiocarcinoma
AT bangyanlstiles transformationofsox9cellsbyptendeletionsynergizeswithsteatoticliverinjurytodrivedevelopmentofhepatocellularandcholangiocarcinoma
_version_ 1718385315278749696